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Abstract
“Why do we have to review our experience in managing 
idiopathic fistula-in-ano regularly?” In order to answer this 
apparently simple question, we reviewed our clinical and      
surgical cases and most important relevant literature to 
find a rational and scientific answer.� It would appear that     
whatever method you adopt in fistula management�� there,  
is a price to pay regarding either rate of recurrence (higher 
with conservative methods) or impairment of continence 
(higher with traditional surgery).� �ince�� at the moment��     
reliable data to identify a treatment as a gold standard in 
the management of anal fistulas are lacking�� the correct 
approach to this condition must consider all the anatomic 
and clinicopathological aspects of the disease; this knowl-
edge joined to an eclectic attitude of the surgeon, who 
should be familiar with different types of treatment, is the 
only guarantee for a satisfactory treatment.� �s a conclu- A   
sion, it is worthwhile to remember that adequate initial 
treatment significantly reduces recurrence�� which�� when it 
occurs, is usually due to failure to recognise the tract and 
primary opening at the initial operation.�
© 2011 Baishideng.� �ll rights reserved.�
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“Why do we have to review our experience in managing 
idiopathic fistula-in-ano regularly?”
The answer to the above question is quite straightfor-
ward: surgeons are aware of  the poor levels of  evidence 
in anal fistula surgery. Despite the high frequency of  sup-
purative ano-perianal lesions of  suspected cryptoglandular 
origin (idiopathic abscess and fistula-in-ano), the ideal 
treatment with outcomes of  no recurrence, minimal incon-
tinence and good quality of  life is still a matter of  debate. 
The traditional surgical treatments which include a division 
of  a continuous part of  the sphincteric complex (in partic-
ular of  the superficial external sphincter in transphincteric 
fistulas) have been strongly challenged, especially in the last 
10-20 years since high rates of  impairment of  continence 
have been reported in several experiences[1,2�.
In spite of  a high successful healing rate varying from 
87% to 100%[��, the traditional invasive methods of  fistulo- 
tomy (with/without draining or slow-cutting seton) and 
fistulectomy (with closure of  internal opening with/with-
out sphincter defect repair) have given way to a number of  
sphincter-sparing methods: endorectal muscular or mu-
cosal advancement flap[����, island flap anoplasty[��, radiof-
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requency ablation[��, fistulous tract filling with fibrin or cy-
anoacrylate glue[�,��, porcine small intestine submucosa-de-
rived anal fistula plug[10�, ayurvedic seton[11�, ligation of  in-
tersphincteric fistula tract (LIFT) procedure[12,1��, glue con-
taining adipose-derived stem cells[1��, and finally VAAFT 
(video-assisted anal fistula treatment) carried out with the 
Storz Meinero fistuloscope®[1��.
This continuous research for an ideal conservative me- 
thod is compelled by concepts recently restated by the 
Standards of  Practice Task Force of  the American Society 
of  Colon and Rectal Surgeons[1�� and by the Association 
of  Coloproctology of  Great Britain and Ireland: division 
of  > �0% of  the external sphincter should be undertaken 
with considerable caution for the relevant risk of  impair-
ment of  anorectal continence, particularly in females, 
those with anterior fistulas, advanced aged patients, history 
of  previous anorectal surgery, childbirth, fistula associated 
with Crohn�s disease and obviously in patients with a his-
tory of  continence impairment not related to the fistula[1��.
Indeed, the necessity to identify patients with high risk 
of  incontinence after classic surgical treatment has been 
stressed over the past few years[1�,1��. These patients, repre-
senting a limited number of  subjects, have been treated with 
a conservative approach usually represented by the non-
cutting draining seton. Thus, considering that the reported 
rate of  impairment of  continence after traditional fistula 
surgery varies from 0% to �2%[20�, the doubt arises that the 
definition of  “incontinence” is not the same for all authors 
and that factors other than the amount of  divided sphincter 
may have a role in continence disturbance. In addition, as 
already observed by Parks[1��, the degree of  impairment of  
anal continence after fistulotomy is not strictly tied to the 
type of  fistula treated and the amount of  severed muscle; 
patients treated for suprasphincteric fistulas (theoretically 
at higher risk of  incontinence) fared better than patients 
treated for transphincteric fistulas[1��. Nevertheless, it seems 
obvious that a risk of  continence impairment is present 
when a sphincter is cut or stretched. Also, a trivial lateral 
internal sphincterotomy for the cure of  fissure or a hemor-
rhoidectomy has a risk of  continence impairment[2�.
As regards fistula treatment, the question is whether a 
real advantage is offered by the new proposed methods, 
especially in the management of  the so-called “complex 
fistulas”.
According to several authors[�,1�,21�, a complex fistula 
must have one or more of  the following features: the tract 
crosses more than �0% to �0% of  the external sphinc-
ter; the fistula is anterior in a female; multiple tracts are 
present; the fistula is recurrent; there is pre-existing in-
continence; the perianal area has been irradiated; there is 
concomitant Crohn�s disease.
A recent review of  randomized studies in the literature[11� 
evaluated some proposed conservative methods vs tradi-
tional surgery (in particular: anal sphincter-preserving seton, 
conventional seton, ayurvedic seton, conventional fistulot-
omy with/without seton, radiofrequency, advancement flap 
with/without fibrin glue, island flap anoplasty, fistulectomy) 
and concluded that there were no significant differences in 
recurrence rates or incontinence rates in any of  the studied 
comparisons, except in the case of  advancement flaps where 
the lowest incontinence rates were reported. However, in 
other experiences of  advancement flap procedures, which 
have been demonstrated as reliable with ��% to 100% heal-
ing rates and 21% recurrences, nevertheless �0% of  patients 
had some impairment of  continence and �% presented 
major disturbance[22,2��. Advancement flap is not a simple 
procedure and damage of  the sphincter is possible. In fact, 
it has been reported[2�� that patients with complex fistulas 
undergoing fistulectomy with immediate sphincter repair 
had less recurrences and continence impairment than pa-
tients submitted to endoanal advancement flap.
It would appear that whatever method you adopt in 
fistula management, there is a price to pay regarding either 
rate of  recurrence (higher with conservative methods) or 
impairment of  continence (higher with traditional surgery).
The point is that it is difficult to establish whether, and 
to what degree, an impairment of  continence has a nega-
tive effect on the quality of  life (QoL) greater than the dis-
tress caused by multiple recurrences of  a fistulous abscess 
or fistula.
The assessment of  personal impairment in relation 
to objective medical findings represents a problem in the 
evaluation of  incontinence. The degree of  sphincter dys-
function does not always correlate with the patient�s sub-
jective awareness of  his functional deficit[2�. QoL param-
eters in fistula surgery are generally based on incontinence 
scores; however, QoL has a multidimensional aspect that 
must be taken into account.
The promising results reported by some authors re-
garding the two least invasive conservative methods, fibrin 
glue[2�� and Surgisis® AFPTM anal fistula plug[10�, are inter-
esting (almost none of  the patients report impairment of  
continence); however, their efficacy in healing the fistulas 
needs to be better evaluated. Healing rates from �1% to 
��% have been reported for fibrin glue and from 1�% to 
��% for the plug[��. Most of  the reported experiences suf-
fer from a small number of  patients and short follow-up 
(often less than � mo), with the highest rate of  success be-
ing for simple uncomplicated fistulas in which traditional 
treatments have also a high rate of  success with low rate 
of  continence impairment[��. Lack of  long-term rand-
omized studies is the other limiting factor for evaluating 
the efficacy of  these procedures. Immediate healing of  a 
fistulous tract does not mean that the infection has disap-
peared. A fistula can recur after months or years in the 
same tract or nearby. It must also be considered that when 
a fistula recurs, patients tend to change surgeon; similarly 
to what happens in recurring inguinal hernia. Regardless, 
the adoption of  bioprosthetic material as a first-line treat-
ment in complex anal fistulas is recommended by several 
authors[2�,2�� ahead of  the more prudent suggestions of  
the consensus conference promoted by the Association of  
Coloproctology of  Great Britain and Ireland[2��.
Since, at the moment, reliable data to identify a treatment 
as a gold standard for the management of  anal fistula are 
lacking, the correct approach to this condition must be to 
consider all the anatomic and clinicopathological aspects of  
the disease. This knowledge joined to an eclectic attitude of  
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the surgeon, who should be familiar with different types of  
treatment, is the only guarantee for a satisfactory outcome.
As a conclusion, it is worthwhile to remember the fol-
lowing concepts and facts: an adequate initial treatment 
significantly reduces recurrence, which when it occurs is 
usually due to failure to recognise the tract and primary 
opening at the initial operation[1�,2�-�1�; many complex fistu-
las are iatrogenic in origin[�2�; in the acute phase (fistulous 
abscess) a radical treatment should be attempted only by 
experienced colorectal surgeons[1��; primary suprasphinc-
teric or extrasphincteric fistulas (according to Parks� clas-
sification) of  cryptoglandular origin are very rare if  not 
nonexistent[�2�; it is essential to have a three dimensional 
vision of  the anorectal region to understand the pathway 
of  diffusion of  cryptoglandular infections; a preoperative 
evaluation of  risk factors for incontinence, including fre-
quency of  defecation, bowel function and sphincter func-
tion, is also mandatory in non-complex fistulas.
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